Important note
This AI stock analysis for Intuitive Surgical is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!
Intuitive Surgical - AI Stock Analysis
Analysis generated July 7, 2025
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. The company's products, such as the da Vinci Surgical System, are designed to improve patient outcomes through less invasive surgical options. Since its foundation in 1995, Intuitive Surgical has been at the forefront of surgical innovations that enhance patient care and optimize operational efficiency for healthcare providers worldwide.
Fundamental Analysis
For the most recent quarter, Intuitive Surgical reported revenue of $2.25 billion, although this represents a decrease of 6.63% compared to the previous quarter, which could be a cause for concern in the short term. However, compared to the same quarter last year, revenue showed a robust increase of 19.19%, indicating positive year-over-year growth.
Net income for the last quarter was $698 million, reflecting an increase of 1.85% compared to the previous quarter, a positive indicator of growth. When compared to the same quarter last year, the net income saw an impressive growth of 28.17%, further underscoring the company's strong performance over a longer horizon.
EBITDA for the last quarter came in at $719 million, which is down 16.36% from the previous quarter. This decrease warrants attention; however, on a year-over-year basis, EBITDA increased by 24.24%, emphasizing positive longer-term trends.
The current Price-to-Earnings (P/E) ratio is 79.95, which may be considered high. A high P/E ratio can signal potential overvaluation and might indicate a bearish outlook in the short term. Additionally, the recent insider selling of the stock could further be a bearish signal.
Technical Analysis
Today's stock price for Intuitive Surgical is $536.53, which is a decrease of 3.69% compared to a month ago. While this decline may concern short-term investors, the stock has increased by 20.70% over the past year, highlighting a positive long-term trend.
The simple moving average for the last 10 days (SMA10) is $540.38, marginally higher than the previous SMA10 of $540.10. This slight increase suggests a potential upward trend in price movement. The Relative Strength Index (RSI) stands at 60.2, indicating neutral market conditions without excessive buying or selling pressure.
Alternative Data Analysis
Intuitive Surgical currently has 337 open positions listed on popular job boards, up by 5% in the last couple of months. This hiring trend is a healthy sign of company expansion. Employee sentiment is also highly positive, with an estimated 88% of employees having a favorable business outlook.
In terms of customer acquisition, Intuitive Surgical's website has seen an estimated 8,000 visitors, a rise of 167% in recent months. This increase in web traffic could potentially translate to greater customer interest and uptake of their products. As for customer engagement, the company's Twitter account maintains 16,000 followers with no significant change in the past months.
Lastly, the AI score generated by AltIndex for Intuitive Surgical is 57, which corresponds to a hold signal. The AI score aggregates fundamental, technical, and alternative data metrics.
Conclusion
Based on the comprehensive analysis, Intuitive Surgical presents a mixed outlook. The fundamental analysis reveals encouraging long-term growth indicators despite short-term revenue and EBITDA concerns. The technical analysis supports a cautiously optimistic long-term view, although short-term fluctuations warrant attention. Alternative data indicates growth and positive sentiment from employees and potential customers. With a current AI score of 57 signaling a hold, potential investors might consider observing market conditions and company performance closely before making investment decisions.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.